Cargando…

A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants

BACKGROUND: The effects of cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) on CMV infection in patients with autoimmune diseases receiving immunosuppressants have not been explored. METHODS: Patients with active systemic lupus erythematosus (SLE) were preemptively monitored for clinicall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruminhent, Jackrapong, Autto, Suphanan, Rotjanapan, Porpon, Ngarmjanyaporn, Pintip, Bushyakanist, Asalaysa, Kirdlarp, Suppachok, O-charoen, Pichaya, Setthaudom, Chavachol, Pisitkun, Prapaporn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231397/ https://www.ncbi.nlm.nih.gov/pubmed/34189173 http://dx.doi.org/10.1093/ofid/ofab248

Ejemplares similares

2655. A Prospective Study of Cytomegalovirus Infection in Active Systemic Lupus Erythematosus Patients with Intense Immunosuppressive Therapy: Epidemiology, Associated Risk Factors, Pathogenesis, and Clinical Outcomes
por: Bushyakanist, Asalaysa, et al.
Publicado: (2019)

1183. A Prospective Epidemiological & Immunological Study of Cytomegalovirus infection in SLE Patients Receiving Immunosuppressant
por: Autto, Suphanan, et al.
Publicado: (2020)

2684. The Prospective Pilot Study of Infectious Complication Surveillance in Active Systemic Lupus Erythematosus Patients with Intense Immunosuppressive Therapy: Cellular Response and Clinical Outcomes
por: Rotjanapan, Porpon, et al.
Publicado: (2019)

A Nationwide Survey of Cytomegalovirus Prevention Strategies in Kidney Transplant Recipients in a Resource-Limited Setting
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

1749. A Nationwide Survey of Cytomegalovirus Prevention Strategies in Kidney Transplant Recipients in a Resource-Limited Setting
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-γ Autoantibodies
por: Laisuan, Wannada, et al.
Publicado: (2020)

2222. A study of the role of trimethoprim-sulfamethoxazole in opportunistic infection prevention in lupus patients taking low-level immunosuppressive treatment: An open-labeled, randomized controlled trial
por: Munthananuchat, Paopat, et al.
Publicado: (2023)

The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus
por: Thanadetsuntorn, Chokchai, et al.
Publicado: (2018)

Vaginal microbiota affects urinary tract infection risk in women with systemic lupus erythematosus: a pilot cross-sectional study from Thailand
por: Rotjanapan, Porpon, et al.
Publicado: (2021)

1147. A study of high-dose influenza vaccination responses compared to standard-dose in lupus patients: an open- labeled, randomized controlled study
por: Yingyounyong, Sasicha, et al.
Publicado: (2023)

SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile
por: Vacharathit, Vimvara, et al.
Publicado: (2021)

The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients
por: Wangriatisak, Kittikorn, et al.
Publicado: (2021)

Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients
por: Seree-aphinan, Chutima, et al.
Publicado: (2023)

280. A cross-sectional pilot study on the relationship of gut microbiota pattern to immunogenicity of influenza vaccine in lupus patients
por: Kiewsanuan, Nathathai, et al.
Publicado: (2023)

Health related quality of life in anti interferon γ autoantibody associated immunodeficiency syndrome measured with EQ5D5L and SF36
por: Temsangsukmanee, Jirat, et al.
Publicado: (2023)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

1743. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality within the First Year after Kidney Transplantation: An Analysis of the National Transplant Registry
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

1198. Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
por: Kirisri, Similan, et al.
Publicado: (2020)

Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report
por: Boongird, Sarinya, et al.
Publicado: (2021)

Cytomegalovirus retinitis in a seronegative patient with systemic lupus erythematosus on immunosuppressive therapy
por: Kelkar, Aditya, et al.
Publicado: (2011)

The relationship of immunosuppression to cytomegalovirus infection.
por: Dowling, J. N., et al.
Publicado: (1976)

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021)

Acute respiratory failure secondary to eosinophilic pneumonia following influenza vaccination in an elderly man with chronic obstructive pulmonary disease
por: Pornsuriyasak, Prapaporn, et al.
Publicado: (2014)

Association of Cytomegalovirus DNA and Immunologic Markers of Cardiovascular Disease
por: Garg, Ankita, et al.
Publicado: (2019)

Performance of real-time PCR and immunofluorescence assay for diagnosis of Pneumocystis pneumonia in real-world clinical practice
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2020)

Efficacy and safety of rituximab biosimilar in refractory lupus
por: Pongtarakulpanit, Nantakarn, et al.
Publicado: (2020)

Epidemiology and Outcomes of Early-Onset and Late-Onset Adenovirus Infections in Kidney Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine
por: Boongird, Sarinya, et al.
Publicado: (2021)

Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3)
por: Boongird, Sarinya, et al.
Publicado: (2022)

In Utero Activation of Natural Killer Cells in Congenital Cytomegalovirus Infection
por: Vaaben, Anna V, et al.
Publicado: (2022)

811. A prospective pilot multicenter study of Aspergillus colonization in the nasal cavity as a surrogate marker of invasive aspergillosis among acute myeloid leukemia patients and allogeneic stem cell transplant recipients
por: Charoonrochana, Natnai, et al.
Publicado: (2023)

Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients
por: Hayuk, Pattorn, et al.
Publicado: (2022)

The Excess Burden of Cytomegalovirus in African American Communities: A Geospatial Analysis
por: Lantos, Paul M., et al.
Publicado: (2015)

Emergence and Persistence of Letermovir-Resistant Cytomegalovirus in a Patient With Primary Immunodeficiency
por: Popping, Stephanie, et al.
Publicado: (2019)

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2022)

SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)
por: Bruminhent, Jackrapong, et al.
Publicado: (2022)

Human Cytomegalovirus Up-Regulates Endothelin Receptor Type B: Implication for Vasculopathies?
por: Yaiw, Koon-Chu, et al.
Publicado: (2015)

Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis
por: Tan, Susanna K., et al.
Publicado: (2016)

Cardiac Microvascular Dysfunction in Women Living With HIV Is Associated With Cytomegalovirus Immunoglobulin G
por: Knudsen, Andreas, et al.
Publicado: (2018)

Cytomegalovirus Latent Infection is Associated with an Increased Risk of COVID-19-Related Hospitalization
por: Alanio, Cécile, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_trbhvpp26o79rtrs49a5jqecrc